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Vascular dysfunction contributes to the pathogenesis of various cardiovascular diseases. Dietary supplements, including ﬁsh oil,
dietary ﬁbers, and various natural products, and exercise training exert vasoprotective eﬀects. However, the mechanisms under-
lying the vasoprotective beneﬁts of dietary supplements and physical activity demand extensive investigation. Accumulating
evidence suggests that inﬂammatory cytokine tumor necrosis factor-alpha (TNFα) plays a pivotal role in the dysregulation of
macrovascularandmicrovascularfunction.TNFαinducesvascularinﬂammation,monocyteadhesiontoendothelialcells,vascular
oxidative stress, apoptosis, and atherogenic response and participates in the regulation of thrombosis and coagulation through
multiple signaling pathways involving NFκB, Sp1, activator protein 1, JNK, p38, STAT3, and so forth. Dietary supplements
and exercise training decrease TNFα production and ameliorate TNFα-mediated pathological changes in vasculature. Thus, the
inhibitory eﬀects of dietary supplements and physical exercise on TNFα production and TNFα signaling may contribute to their
vasoprotective properties.
1.Introduction
Endothelial dysfunction is an early indicator of cardiovascu-
lar diseases, including that seen in type 2 diabetes [1]. Accu-
mulating evidence suggests that mediators of inﬂammation
may be pathogenic by inducing vascular dysfunction [2].
Among the various inﬂammatory factors, tumor necrosis
factor-alpha (TNFα) plays a pivotal role in the regulation of
vascular function in various pathological status [3]. TNFα
belongstotheTNFsuperfamilyandisproducedbymanycell
types, including macrophages, lymphocytes, and ﬁbroblasts,
and so forth [4–6]. TNFα can either exist in a membrane-
boundformorbesecretedasasolublecytokinethatisableto
diﬀuse from the sites of its initial production [7]. It can bind
to, and thus functions through its receptors, TNF receptor
type 1 (TNFR1) and TNF receptor type 2 (TNFR2) [8]. Die-
tary supplements and exercise are emerging as eﬀective ad-
junctive therapies targeting endothelial dysfunction and vas-
cular wall inﬂammation [3, 9, 10]. This review summariz-
ed the vasoprotective eﬀects of dietary supplements and
exercises by inhibiting TNFα production and TNFα-induced
signaling (Figures 1 and 2).
2. DietarySupplements
During the past few decades, there has been renewed interest
in dietary components that might favorably reduce risk of
vasculardysfunction.Fishoil,dietaryﬁber,andvariousnatu-
ral products have sparked intense interest in epidemiological
studies. Extensive exploration of the underlying mechanisms
of their healthy beneﬁts became very important to develop
new adjunctive therapies from those dietary supplements
in order to delay or prevent the development of vascular
disorders.
2.1. Fish Oil. Fish and other marine life serve as rich sources
ofaclassofpolyunsaturatedfattyacids[11].Theyarenamed
as omega-3 or n-3 fatty acids because the ﬁrst of the several2 Experimental Diabetes Research
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Figure 1:Dietarysupplements(ﬁshoil,dietaryﬁber,andvariousﬂavonoidandnonﬂavonoidnaturalproducts)exertvasoprotectivebeneﬁts
by inhibiting TNFα production and its downstream signaling pathways. There are dichotomies in the eﬀects of exercise training on TNFα
production. Whereas acute exercise has been reported to increase the production of proinﬂammatory cytokines, chronic exercise reduces
TNFα levels.
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Figure 2: Multiple mechanisms are involved in the vasoprotective eﬀects of dietary supplements and exercise by inhibiting TNFα signaling.
double bonds occur three carbon atoms away from the ter-
minal end of the carbon chain [11]. The three n-3 polyun-
saturatedfattyacids(n-3PUFAs)includealphalinolenicacid
(LNA),eicosapentenoicacid(EPA),anddocosahexenoicacid
(DHA) [12]. The role of ﬁsh oil lipids in regulating TNFα
expressionandTNFα-inducedinﬂammationinvascularcells
hasbeenextensivelystudiedinthepastdecades.Dietarysup-
plementation with n-3 PUFA improved endothelial function
andreducedcirculatinglevelofTNFαinoﬀspringofpatients
with type 2 diabetes [13]. Omega-3 fatty acid markedly sup-
pressed the production of TNFα by monocytes in response
to endotoxin. In addition, it also signiﬁcantly inhibited
both monocyte-endothelium adhesion and transendothelial
monocyte migration [14]. One of the mechanisms by which
ﬁshoilalterstheabilityoflymphocytestobindtoendothelial
cells may be its eﬀects on inhibiting adhesion molecule ex-
pression induced by proinﬂammatory cytokines such as
TNFα [15, 16]. Moreover, dietary ﬁsh oil resulted in a 50%
reduction in concanavalin A (Con A), which enhanced lym-
phocyte adhesion to TNFα-stimulated endothelial cells [17].
EPA and DHA inhibited TNFα-induced monocyte adhesion
to activated endothelial cells in vitro by aﬀecting endothelial
platelet-activating factor (PAF) generation [18]. Dietary ﬁsh
oil supplementation inhibited TNFα production by human
peripheral blood mononuclear cells [19]. Acute cod liver oil
consumption reduced circulating level of TNFα and intercel-
lular adhesion molecule-1 (ICAM-1) in healthy individuals
[20]. These studies suggest that inhibition of inﬂammatory
cell adhesion/migration induced by inﬂammatory cytokine
TNFα may partially explain the protective eﬀects of the ﬁsh-
oil-rich diet against vascular inﬂammation.
2.2. Dietary Fiber. A high intake of ﬁber-rich carbohydrates
might contribute to weight management and is beneﬁcial for
reducing the risk of cardiovascular diseases and diabetes. As
a mucilaginous material prepared from the seed husk of
plants of the Plantago genus, psyllium is an excellent source
of mainly soluble ﬁber. Prolonged feeding of a 3.5% P. ovata
husk-supplemented diet prevented endothelial dysfunction
and the development of hypertension in obese Zucker rats.
The diet also decreased body weight gain, reduced hyper-
insulinemia and dyslipidemia, restored plasma adiponectinExperimental Diabetes Research 3
concentration, and decreased circulating TNFα concentra-
tion [21]. In diabetic women, dietary intake of whole grain,
bran, and cereal ﬁbers decreased circulating C-reactive pro-
tein (CRP) and TNFR2 concentration [22].
2.3. Natural Products. There is a growing body of literature
supporting the beneﬁcial eﬀe c t so fn a t u r a lp r o d u c t so no p t i -
mal health and disease prevention. As a group of chemical
substances found in plants, polyphenols are characterized by
the presence of more than one phenol unit or building block
per molecule. The health beneﬁts of several speciﬁc polyphe-
nols on vascular dysfunction are well established.
2.3.1. EGCG and other Flavonoid Polyphenolics. Flavonoids
are most commonly known for their antioxidative and anti-
inﬂammatory activity. Over 5000 naturally occurring ﬂavon-
oids have been identiﬁed from various plants. Epigallocate-
chin gallate (EGCG), a green tea catechin, is the major com-
ponent of green tea ﬂavonoids. EGCG signiﬁcantly attenuat-
ed the elevated TNFα levels and impaired vasodilator re-
sponse to acetylcholine induced by low density lipoprotein
(LDL) in a rat model [23]. EGCG decreases TNFα-induced
fractalkine expression by suppressing nuclear factor-kappa
B( N F κB) [24] and inhibited TNFα-induced monocyte che-
moattractant protein-1 (MCP-1) production and the acti-
vation of activator protein-1 (AP-1) in vascular endothelial
cells via heme oxygenase-1- (HO-1) dependent mechanisms
[25, 26]. Apigenin is a ﬂavone that is the aglycone of apiin.
Apigeninprofoundlyreducedmonocytesadhesiontohuman
umbilical vein endothelial cells (HUVECs) monolayer by
suppressing TNFα-stimulated upregulation of vascular cell
adhesion protein-1 (VCAM-1), ICAM-1, and E-selectin
mRNA expression [27] .A saﬂ a v o n o l ,q u e r c e t i nd o w n r e g -
ulated TNFα-induced ICAM-1 and E-selectin expression in
human endothelial cells [28–30]. Isoﬂavone genistein inhib-
ited TNFα-induced apoptosis in human aortic endothelial
cells as determined by caspase-3 activation, 7-amino actino-
mycin D staining, in situ apoptotic cell detection, and DNA
laddering [31]. These studies provide a novel mechanism
whereﬂavonoidscouldprovidedirectvasoprotectivebeneﬁts
in inﬂammatory cardiovascular diseases by inhibiting TNFα
and TNFα-induced inﬂammation.
2.3.2. Resveratrol and other Nonﬂavonoid Polyphenolics. For
the last few decades, extensive work has been done to estab-
lish the biological activities and pharmacological actions of
resveratrol and other nonﬂavonoid polyphenolics in protect-
ing against vascular dysfunction in various disease states.
Resveratrolisanaturalphytophenolthatcanbeextracted
from grape skins [32]. Epidemiological studies suggest that
Mediterranean diet, which is rich in resveratrol, is associat-
ed with reduced risk of cardiovascular diseases [33]. Resver-
atrol ameliorated endothelial apoptosis by inhibiting TNFα-
elicited increases in caspase-3/7 activity in endothelial cells
and cultured rat aortas [34]. The protective eﬀect of res-
veratrol was attenuated by the inhibition of glutathione
peroxidase and HO-1, suggesting a role for antioxidant sys-
tems in the antiapoptotic action of resveratrol [34]. In
additiontoantiapoptoticeﬀects,resveratrolinhibitedTNFα-
stimulated monocytes adhesion to endothelial cells [35]. The
mechanism might be through inhibiting TNFα-induced
NFκB activation and inﬂammatory gene expression [36].
Matrixmetalloproteinases(MMPs)playanimportantrolein
extracellular matrix metabolism, which is a critical contrib-
utortoarterialpathology.Resveratroldose-dependentlysup-
pressed TNFα-induced proliferation and expression of
MMP-9 in vascular smooth muscle cells through the tran-
scription factors NFκB and AP-1 [37]. Upregulated expres-
sionoffractalkineisassociatedwithincreasedatherosclerotic
lesion formation in apolipoprotein E−/− (ApoE−/−)m i c e
[38]. Resveratrol strongly suppressed TNFα-induced frac-
talkine expression in endothelial cells through the suppres-
sion of NFκB and Sp1 transcription factor activities [39].
Resveratrol activates eNOS and increases muscle microvas-
cular blood volume and ﬂow via an NO-dependent mecha-
nism, but systemic infusion of TNFα prevented resveratrol-
induced muscle microvascular recruitment [40]. There-
fore,resveratrolprotectedagainstTNFα-inducedendothelial
apoptosis, monocytes adhesion, cell proliferation, atheroge-
nesis,anddysregulationofvasomotorfunctionthroughmul-
tiple signaling pathways. Resveratrol also suppressed plasma
TNFα concentration following inﬂammatory stimulation by
lipopolysaccharide (LPS) [41] and modulates vascular TNFα
expression [42]. Aortic TNFα expression was signiﬁcantly
increased in type 2 diabetic mice, accompanied by impaired
endothelium-dependent vasorelaxation. Chronic resveratrol
treatment improved endothelial function and reduced vas-
cular TNFα expression [42]. Both anti-TNFα treatment and
resveratrol markedly inhibited the NFκB pathway through
suppressing inhibitor of NFκB( I κB) protein phosphoryla-
tion [42, 43], and signiﬁcantly attenuated vascular oxidative
stress and improved NO production. Thus, resveratrol medi-
ated vasculoprotective eﬀects by inhibiting TNFα expression
and TNFα-induced signaling pathway.
Curcumin is another important natural polyphenol. It
inhibited TNFα-mediated adhesion of monocytes to endo-
thelial cells by suppression of cell surface expression of ad-
hesion molecules and of NFκBa c t i v a t i o n[ 44, 45]. The
mechanism was through inhibiting TNFα-induced IκBα
degradation and the nuclear import of NFκB. In contrast,
curcumin inhibited AP-1 by direct interaction of curcumin
with AP-1 binding to its DNA binding motif, therefore, re-
duced the expression of endothelial tissue factor (TF), the
central mediator of coagulation [46]. Thrombomodulin
(TM) functions as a cofactor in the thrombin-induced ac-
tivation of protein C in the antithrombotic pathway. Cur-
cumin eﬀectively blocked TNFα-induced downregulation of
TM and endothelial protein C receptor (EPCR) at both
mRNA and protein levels in several human endothelial cells
[47].Curcuminalsoreducedtheintracellularreactiveoxygen
species (ROS) levels, phosphorylation of c-Jun N-terminal
kinases (JNK), p38 mitogen-activated protein kinases (p38),
and signal transducer and activator of transcription-3
(STAT3), and the expression of ICAM-1, MCP-1, interleu-
kin-8(IL-8),andlectin-likeoxidisedLDLreceptor-1(LOX-1)
in TNFα-stimulated HUVECs [48, 49].4 Experimental Diabetes Research
In summary, the anti-inﬂammatory, antithrombotic, an-
tiapoptotic, and antioxidative eﬀects contribute to the health
beneﬁts of those nutritional supplements, which protect
againstvasculardamageatleastpartiallybydecreasingTNFα
production and inhibiting TNFα-mediated pathological
changes through multiple signaling pathways.
3. Exercise
There are dichotomies in the eﬀects of exercise on the pro-
duction of inﬂammatory cytokines. A cross-sectional study
suggested that inﬂammatory markers, such as CRP, IL-6,
and TNFα, were lower in older adults with higher levels of
exercise and nonexercise activity and in antioxidant sup-
plement users regardless of exercise level [50]. However, a
study using treadmill running mice showed that exercise
could increase plasma IL-6 concentrations and lung TNFα
mRNA expression [51]. This dichotomy may be attributed to
the intensity of exercise. Chronic heart failure is associated
with increased levels of TNFα and markers of endothelial
damage, including soluble ICAM-1 (sICAM-1) and E-selec-
tin. Whereas acute bouts of exercise lead to an increase in
proinﬂammatory cytokines and markers of endothelial dam-
age; these eﬀects were not seen when exercise was performed
chronically in chronic heart failure patients [52]. A 10-week
moderateintensityexercisetrainingimprovedcoronaryarte-
riolar endothelial function and reduced TNFα level in the
myocardial tissue homogenate of type 2 diabetic mice [53].
Interestingly,dietplusexercisetrainingmayexertremarkable
beneﬁts when either diet or exercise alone could not dem-
onstrate evident beneﬁts. In obese postmenopausal women,
diet plus exercise, but not diet alone, decreased plasma
levels of CRP, IL-6, sIL-6R, and sTNFR1 and increased basal
and postreceptor stimulated lipolysis in both abdominal and
gluteal regions [54]. After eccentric exercise in untrained
men, Omega-3 fatty acids supplementation attenuates plas-
ma TNFα level [55]. These results suggest that diet supple-
mentationinexercisetrainingiseﬀectiveinreducingchronic
inﬂammation.
4.Perspectives
It is of interest to notice that nutrition and exercise have al-
most always been studied separately although they are close-
ly related and may amplify each other to maximize their ben-
eﬁcial eﬀects. Studies of diet/dietary supplements plus exer-
cise training in animals and human being subjects would
be meaningful to explore the mechanisms of dietary supple-
mentsandexerciseinprotectingagainstvasculardysfunction
and the involvement of TNFα signaling.
5. Concluding Remarks
In conclusion, TNFα is known to amplify several signaling
pathwaysleadingtovascularinﬂammation,apoptosis,oxida-
tive stress, and thrombosis, which are key mediators in the
pathogenesis of vascular dysfunction. Dietary supplements
and/or exercise decrease TNFα level and inhibit TNFα-med-
iated pathological changes through multiple signaling path-
ways, whereby exerting vasoprotective beneﬁts. We believe
that further investigations in this exciting ﬁeld would facil-
itate the development of dietary supplements and exercise
as adjunctive therapies in the management of cardiovascular
diseases.
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